KG: Summary for KING PHARMACEUTICALS - Yahoo! Canada Finance

	Sign In [New User? Sign Up]	Finance Home \|Help

Wednesday, February 10, 2010, 6:03am EST - Canadian Markets open in 3 hours and 27 minutes.

To create a watchlist or portfolio of shares, Sign-in or Register

King Pharmaceuticals Inc. (KG)

On Feb 9: 11.44 USD 0.00 (0.00%)

MORE ON KG

Quotes

Summary

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

KING PHARMACEUTICALS (NYSE:KG) Delayed quote data

Last Trade:	11.44 USD
Trade Time:	Feb 9
Change:	0.00 (0.00%)
Prev Close:	11.44
Open:	N/A
Bid:	N/A
Ask:	N/A
1y Target Est:	14.13

Day's Range:	N/A - N/A
52wk Range:	5.86 - 13.20
Volume:	0
Avg Vol (3m):	2,859,660
Market Cap:	2.84B
P/E (ttm):	N/A
EPS (ttm):	-1.93
Div & Yield:	N/A (N/A%)

1d 5d 3m 6m 1y 2y 5y max

Free Annual Reports

Add KG to Portfolio

Download Data

HEADLINES

•	King Pharmaceuticals Appoints Two New Members to Its Board of Directors
	Marketwire (Tue 4:55pm)

•	King Launches PainBalance(R): Educational Initiative to Help Reduce the Burden of Pain
	PRNewswire (Wed, Feb 3)

•	Coverage initiated on King Pharms by Jefferies & Co
	Briefing.com (Tue, Feb 2)

•	Why Pharma Is Pushing Its Drug Pushers Out
	at Minyanville.com (Thu, Jan 21)

•	UPDATE - King Pharmaceuticals reviews animal health unit
	at Reuters (Fri, Jan 15)

•	KING PHARMACEUTICALS INC Files SEC form 8-K, Regulation FD Disclosure
	EDGAR Online (Fri, Jan 15)

•	King Pharmaceuticals To Present At J.P. Morgan Healthcare Conference
	Business Wire (Tue, Jan 5)

•	King Pharmaceuticals: A Look Ahead to Dec 2009 Quarterly Results
	at Seeking Alpha (Thu, Dec 31)

•	[video] Stealth Generic Drug Play: 1 Minute Trade
	at TheStreet.com (Fri, Dec 11)

•	ZymoGenetics claims court win versus King
	at bizjournals.com (Thu, Dec 10)

•	KING PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers
	EDGAR Online (Wed, Dec 9)

More Headlines for KG...

ANALYST

EPS Est (next year) (Dec-09) :	1.08
EPS Est (in 2 years) (Dec-10) :	1.00
Avg Rec (current)*:	1.8
PEG Ratio:	1.60

* (Strong Buy) 1.0 - 5.0 (Strong Sell)

Analyst Opinion - Estimates

BUSINESS SUMMARY

King Pharmaceuticals, Inc. research and develops, manufactures, markets, and sells branded prescription pharmaceutical products and animal health products worldwide.

Full Company Profile

Add to Portfolio

Email to a Friend

•